Inhibition of proteasome-dependent degradation of Wee1 in G2-arrested Hep3B cells by TGFβ1

Molecular Carcinogenesis

Volumn 36, Issue 4, 2003, Pages 171-182

  Hashimoto, Osamu ^a   Ueno, Takato ^a   Kimura, Rina ^a   Ohtsubo, Motoaki ^a   Nakamura, Toru ^a   Koga, Hironori ^a   Torimura, Takuji ^a   Uchida, Sanae ^b   Yamashita, Katsumi ^b   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

CDC2; Cell cycle; Cyclin; MG132; p21cip1; PD0166285

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN B1; CYCLIN DEPENDENT KINASE 2; DNA; MESSENGER RNA; PD 0166285; PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEASOME; PROTEIN INHIBITOR; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; RNA; TRANSFORMING GROWTH FACTOR BETA1; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; AUTORADIOGRAPHY; CELL CYCLE G2 PHASE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; NORTHERN BLOTTING; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; CYSTEINE ENDOPEPTIDASES; DNA PRIMERS; G2 PHASE; HUMANS; KINETICS; LIVER NEOPLASMS; MULTIENZYME COMPLEXES; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-TYROSINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 0037387152     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/mc.10111     Document Type: Article

References (50)

1. Miyazono K, ten Dijke P, Heldin CH. TGFβ signaling by Smad proteins. Adv Immunol 2000;75:115-157.
2. Bedossa P, Peltier E, Terris B, Franco D, Poynard T. Transforming growth factor-beta 1 (TGFβ1) and TGFβ1 receptors in normal, cirrhotic, and neoplastic human livers. Hepatology 1995;21:760-766.
3. Shirai Y, Kawata S, Tamura S, et al. Plasma transforming growth factor β1 in patients with hepatocellular carcinoma. Cancer 1994;73:2275-2279.
4. Eppert K, Scherer SW, Ozcelik H, et al. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996;86:543-552.
5. Santoni-Rugiu E, Jensen MR, Factor VM, Thorgeirsson SS. Acceleration of c-myc-induced hepatocarcinogenesis by coexpression of transforming growth factor (TGF)α in transgenic mice is associated with TGFβ1 signaling disruption. Am J Pathol 1999;154:1693-1700.
6. Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res 1996;56:2527-2530.
7. Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell 1998;94:703-714.
8. Massague J, Blain SW, Lo RS. TGFβ signaling in growth control, cancer, and heritable disorders. Cell 2000;103:295-309.
9. Ewen ME, Sloss HK, Whitehouse LL, Livingston DM. TGFβ inhibition of CDK4 synthesis is linked to cell cycle arrest. Cell 1993;74:1009-1020.
10. Iavarone A, Massague J. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGFβ in cells lacking the CDK inhibitor p15. Nature 1997;387:417-422.
11. 1 independent of effects on gene transcription. Cancer Res 1995;55:1452-1457.
12. Malliri A, Yeudall WA, Nikolic M, Crouch DH, Parkinson EK, Ozanne B. Sensitivity to transforming growth factor β1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC downregulation and p21waf1 induction are important early events. Cell Growth Differ 1996;7:1291-1304.
13. Warner BJ, Blain SW, Seoane J, Massague J. Myc down-regulation by transforming growth factor β required for activation of the p15 (Ink4b) G (1) arrest pathway. Mol Cell Biol 1999;19:5913-5922.
14. Blain SW, Massague J. Different sensitivity of the transforming growth factor β cell cycle arrest pathway to c-Myc and MDM-2. J Biol Chem 2000;275:32066-32070.
15. Morgan DO. Cyclin-dependent kinases: Engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 1997;13:261-291.
16. Nurse P. Checkpoint pathways come of age. Nature 1990;344:503-508.
17. Nurse P. Universal control mechanism regulating onset of M-phase. Cell 1997;91:865-867.
18. Poon RY, Chau MS, Yamashita K, Hunter T. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res 1997;57:5168-5178.
19. Booher RN, Holman PS, Fattaey A. Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity. J Biol Chem 1997;272:22300-22306.
20. Honda R, Tanaka H, Ohba Y, Yasuda H. Mouse p87wee1 kinase is regulated by M-phase specific phosphorylation. Chromosome Res 1995;3:300-308.
21. 2 cell cycle delay by interfering with the intracellular trafficking of Cdc2-cyclin B1 complexes. Mol Cell Biol 1999;19:5113-5123.
22. McGowan CH, Russell P. Human Wee1 kinase inhibits cell division by phosphorylating p34CDC2 exclusively on Tyr15. EMBO J 1993;12:75-85.
23. Mueller PR, Coleman TR, Dunphy WG. Cell cycle regulation of a Xenopus Wee1-like kinase. Mol Biol Cell 1995;6:119-134.
24. Parker LL, Piwnica-Worms H. Inactivation of the p34CDC2-cyclin B complex by the human WEE1 tyrosine kinase. Science 1992;257:1955-1957.
25. Watanabe N, Broome M, Hunter T. Regulation of the human WEE1 Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J 1995;14:1878-1891.
26. Russell P. Checkpoints on the road to mitosis. Trends Biochem Sci 1998;23:399-402.
27. McGowan CH, Russell P. Cell cycle regulation of human WEE1. EMBO J 1995;14:2166-2175.
28. Michael WM, Newport J. Coupling of mitosis to the completion of S phase through Cdc34-mediated degradation of Wee1. Science 1998;282:1886-1889.
29. Sia RA, Bardes ES, Lew DJ. Control of Swe1p degradation by the morphogenesis checkpoint. EMBO J 1998;17:6678-6688.
30. Boddy MN, Furnari B, Mondesert O, Russell P. Replication checkpoint enforced by kinases Cds1 and Chk1. Science 1998;280:909-912.
31. 2 DNA damage checkpoint inhibiting CDC2 by Y15 phosphorylation. EMBO J 1997;16:545-554.
32. Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 1979;282:615-616.
33. Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyano K, Sato J. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. Jpn J Cancer Res 1984;75:151-158.
34. Farshid M, Tabor E. Expression of oncogenes and tumor suppressor genes in human hepatocellular carcinoma and hepatoblastoma cell lines. J Med Virol 1992;38:235-239.
35. Muller M, Stand S, Hug H, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 1997;99:403-413.
36. 1. Cancer Res 1992;52:385-388.
37. Matsuzaki K, Date M, Furukawa F, et al. Regulatory mechanisms for transforming growth factor β as an autocrine inhibitor in human hepatocellular carcinoma: Implications for roles of smads in its growth. Hepatology 2000;32:218-227.
38. Wang Y, Li J, Booher RN, et al. Radiosensitization of p53 mutant cells by PD0166285, a novel G(2) checkpoint abrogator. Cancer Res 2001;61:8211-8217.
39. 1 arrest triggered by p16INK4a, TGFβ, and contact inhibition. Cell 1999;97:53-61.
40. Meikrantz W, Schlegel R. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. J Biol Chem 1996;271:10205-10209.
41. Choi KS, Eom YW, Kang Y, et al. Cdc2 and Cdk2 kinase activated bytransforming growth factor β1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells. J Biol Chem 1999;274:31775-31783.
42. Fan G, Ma X, Kren BT, Steer CL. The retinoblastoma gene product inhibits TGFβ1 induced apoptosis in primary rat hepatocytes and human HuH-7 hepatoma cells. Oncogene 1996;12:1909-1919.
43. 2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Mol Cell Biol 1998;18:629-643.
44. 2 DNA damage checkpoint. J Biol Chem 2000;275:30638-30643.
45. 2 arrest after DNA damage. Science 1998;282:1497-1501.
46. Engel ME, Datta PK, Moses HL. RhoB is stabilized by transforming growth factor β and antagonizes transcriptional activation. J Biol Chem 1998;273:9921-9926.
47. Tang Z, Coleman TR, Dunphy WG. Two distinct mechanisms for negative regulation of the Wee1 protein kinase. EMBO J 1993;12:3427-3436.
48. Walter SA, Guadagno SN, Ferrell JE Jr. Activation of Wee1 by p42 MAPK in vitro and in cycling xenopus egg extracts. Mol Biol Cell 2000;11:887-896.
49. Lee J, Kumagai A, Dunphy WG. Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol Biol Cell 2001;12:551-563.
50. Rhind N, Russell P. Roles of the mitotic inhibitors Wee1 and Mik1 in the G(2) DNA damage and replication checkpoints. Mol Cell Biol 2001;21:1499-1508.